SAB Biotherapeutics Inc. (SABSW) Balance Sheet Analysis - Assets, Liabilities & Financial Position - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    SAB Biotherapeutics Inc.

    NASDAQ: SABSW · Real-Time Price · USD
    0.02
    -0.02 (-48.98%)
    At close: Jun 09, 2025, 11:03 AM

    SAB Biotherapeutics Balance Sheet Statement

    Financials in USD. Fiscal year is undefined.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Cash & Equivalents
    		 8.9M 56.57M 15.05M 33.21M
    Short-Term Investments
    		 11.86M n/a n/a n/a
    Long-Term Investments
    		 n/a n/a n/a n/a
    Other Long-Term Assets
    		 482.1K 350.23K 467.69K n/a
    Receivables
    		 54.95K n/a 5.56M 8.01M
    Inventory
    		 n/a n/a n/a n/a
    Other Current Assets
    		 2.98M 2.34M n/a 6.34M
    Total Current Assets
    		 23.79M 58.91M 22.1M 48.42M
    Property-Plant & Equipment
    		 19.92M 24.68M 28.34M 30.95M
    Goodwill & Intangibles
    		 n/a n/a n/a n/a
    Total Long-Term Assets
    		 20.4M 25.03M 28.81M 30.95M
    Total Assets
    		 44.2M 83.94M 50.9M 79.37M
    Account Payables
    		 1.69M 945.93K 3.68M 4.46M
    Deferred Revenue
    		 n/a 1.32M n/a 100K
    Short-Term Debt
    		 811.84K 1.05M 1.4M 1.8M
    Other Current Liabilities
    		 5.47M 4.49M 7.47M 13.99M
    Total Current Liabilities
    		 7.98M 10.81M 14.99M 24.68M
    Long-Term Debt
    		 n/a n/a 541.64K n/a
    Other Long-Term Liabilities
    		 6.39M 11.77M 320.93K 10.72M
    Total Long-Term Liabilities
    		 10.25M 15.83M 4.85M 16.14M
    Total Liabilities
    		 18.23M 26.64M 19.85M 40.82M
    Total Debt
    		 4.67M 5.91M 5.93M 6.74M
    Common Stock
    		 935.00 929.00 5.09K 4.35K
    Retained Earnings
    		 -124.17M -90.06M -47.87M -29.13M
    Comprehensive Income
    		 -135.41K 26.42K n/a n/a
    Shareholders Equity
    		 25.97M 57.3M 31.06M 38.55M
    Total Investments
    		 11.86M n/a n/a n/a

    Add to Watchlist